The Allergic Asthma drugs in development market research report provides comprehensive information on the therapeutics under development for Allergic Asthma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Allergic Asthma. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Allergic Asthma and features dormant and discontinued products.
GlobalData tracks 62 drugs in development for Allergic Asthma by 58 companies/universities/institutes. The top development phase for Allergic Asthma is preclinical with 36 drugs in that stage. The Allergic Asthma pipeline has 50 drugs in development by companies and 12 by universities/ institutes. Some of the companies in the Allergic Asthma pipeline products market are: Changchun GeneScience Pharmaceutical, Inmunotek and Oneness Biotech.
The key targets in the Allergic Asthma pipeline products market include Immunoglobulin E, Mast/Stem Cell Growth Factor Receptor Kit, and Trans Acting T Cell Specific Transcription Factor GATA 3.
The key mechanisms of action in the Allergic Asthma pipeline product include Immunoglobulin E Inhibitor with eight drugs in Pre-Registration. The Allergic Asthma pipeline products include ten routes of administration with the top ROA being Oral and 16 key molecule types in the Allergic Asthma pipeline products market including Monoclonal Antibody, and Small Molecule.
Allergic Asthma overview
Allergic asthma is a type of asthma triggered by exposure to allergens, substances that induce an allergic reaction in susceptible individuals. When someone with allergic asthma encounters these triggers, their immune system responds by inflaming and constricting the airways, leading to symptoms of asthma. Common allergens that can trigger asthma include pollen, dust mites, pet dander, mold, cockroach droppings, and certain foods. The symptoms of allergic asthma are similar to those of other types of asthma and may include wheezing, coughing, shortness of breath, chest tightness, and difficulty breathing. Symptoms are often worse at night or early in the morning. Allergic asthma is diagnosed through a combination of medical history, physical examination, lung function tests (spirometry), and allergy testing to identify specific triggers.
For a complete picture of Allergic Asthma’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
